MBD2 can mediate asthma epigenetics by interpreting DNA methylation and inducing posttranscriptional histone modification through binding the target gene to change the chromatin structure and also affects the Th17 expression in severe asthma, showing the possibility of therapeutic target in severe asthma. This evidence concerns the gene MBD2 and asthma.